KRISHNA INST OF MED SCI L (KIMS) financials

KRISHNA INST OF MED SCI L (KIMS) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 citie…

Market Cap: ₹28,796Cr.
Current Price: ₹686
Stock P/E: 105
ROE: 11.5%
ROCE: 13.0%
Book Value: ₹60.7
Dividend Yield: 0.00%
52W High / Low: ₹858/576

In Jun 2026, KRISHNA INST OF MED SCI L (KIMS) reported sales ₹484 Cr and net profit ₹66 Cr.

Annual TTM: sales ₹1,812 Cr, net profit ₹268 Cr.

Shareholding: Promoters 32.49% (Jun 2026), FIIs 14.75% (Jun 2026), DIIs 34.42% (Jun 2026), Public 18.32% (Jun 2026), No. of Shareholders 94,730% (Jun 2026).

KIMS quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	363	348	346	373	430	442	456	484
Expenses	252	245	237	276	318	314	326	365
Operating Profit	111	103	109	98	112	128	130	118
OPM %	31%	30%	31%	26%	26%	29%	29%	24%
Other Income	7	21	35	12	12	14	11	31
Interest	5	7	8	12	18	22	27	33
Depreciation	14	15	15	18	20	23	26	27
Profit before tax	99	102	120	80	86	98	89	89
Tax %	27%	25%	22%	26%	26%	26%	26%	25%
Net Profit	72	76	94	59	64	72	66	66
EPS in Rs	1.80	1.91	2.34	1.47	1.59	1.81	1.65	1.58
Raw PDF	—	—	—	—	—	—	—	—

KIMS profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	790	933	1,143	1,132	1,222	1,384	1,702	1,812
Expenses	584	624	740	768	857	963	1,229	1,323
Operating Profit	206	309	403	364	366	421	473	489
OPM %	26%	33%	35%	32%	30%	30%	28%	27%
Other Income	7	8	21	23	18	68	50	68
Interest	24	18	9	5	7	28	84	99
Depreciation	43	45	45	45	58	58	86	96
Profit before tax	147	254	371	337	318	403	353	362
Tax %	17%	26%	25%	25%	26%	25%	26%	—
Net Profit	121	189	278	252	235	303	261	268
EPS in Rs	3.25	4.86	6.96	6.31	5.88	7.57	6.52	6.63
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	—

KIMS balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	74	74	78	80	80	80	80	80
Reserves	429	550	830	1,298	1,551	1,786	2,088	2,349
Borrowings	187	186	131	18	4	326	708	1,526
Other Liabilities	166	147	175	173	177	204	313	330
Total Liabilities	857	957	1,214	1,569	1,812	2,397	3,189	4,285
Fixed Assets	567	559	582	592	612	674	773	1,534
CWIP	0	2	8	13	16	292	530	116
Investments	80	178	213	542	826	1,062	1,226	1,523
Other Assets	210	218	411	422	358	368	660	1,113
Total Assets	857	957	1,214	1,569	1,812	2,397	3,189	4,285

KIMS cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	109	161	291	284	271	262	294	292
Cash from Investing Activity	-99	-108	-317	-375	-238	-569	-627	-956
Cash from Financing Activity	-12	-24	25	76	-15	289	339	662
Net Cash Flow	-2	28	0	-15	18	-18	6	-1
Free Cash Flow	63	140	219	215	150	-58	-12	-63
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	245%	101%	108%	94%	95%	95%	91%	79%

KIMS shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	38.82%	38.82%	38.82%	34.11%	34.11%	34.11%	34.11%	32.49%
FIIs	15.85%	15.68%	15.44%	15.54%	15.03%	14.33%	14.57%	14.75%
DIIs	32.29%	32.05%	31.95%	31.65%	32.12%	32.72%	32.50%	34.42%
Public	13.03%	13.45%	13.78%	18.68%	18.74%	18.85%	18.82%	18.32%
No. of Shareholders	77,617	95,468	1,01,895	1,08,955	1,04,872	1,01,599	93,333	94,730

KIMS key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	52	46	29	28	39	44	49	60
Inventory Days	42	44	30	38	—	—	—	—
Days Payable	161	158	155	118	—	—	—	—
Cash Conversion Cycle	-68	-68	-96	-52	39	44	49	60
Working Capital Days	2	-4	-29	6	12	3	-23	-35
ROCE %	3%	23%	30%	31%	23%	17%	16%	13%

KIMSUpdated 19 Oct 2026, 5:42

Krishna Inst Of Med Sci L

KIMSUpdated 19 Oct 2026, 5:42

Market Cap

₹28,796Cr.

Current Price

₹686

High / Low

₹858/576

Stock P/E

105

ROE11.5%

ROCE13.0%

Book Value₹60.7

Face Value₹2.00

Dividend Yield0.00%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	299	0	207	4	12	84	25	63	1.56
Sep 2023	316	0	218	4	13	89	26	66	1.65
Dec 2023	302	1	215	4	13	78	25	58	1.46
Mar 2024	305	2	218	4	20	68	29	48	1.2
Jun 2024	327	4	234	5	14	82	26	61	1.52
Sep 2024	363	5	252	7	14	99	27	72	1.8
Dec 2024	348	7	245	21	15	102	25	76	1.91
Mar 2025	346	8	237	35	15	120	22	94	2.34
Jun 2025	373	12	276	12	18	80	26	59	1.47
Sep 2025	430	18	318	12	20	86	26	64	1.59
Dec 2025	442	22	314	14	23	98	26	72	1.81
Mar 2026	456	27	326	11	26	89	26	66	1.65
Jun 2026	484	33	365	31	27	89	25	66	1.58

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2016	485	36	380	4	34	38	37	24	0.69
Mar 2017	536	32	422	3	34	51	37	33	0.91
Mar 2018	628	88	562	3	38	-57	43	-81	-2.27
Mar 2019	707	33	652	6	41	-13	225	-44	-1.17
Mar 2020	790	24	584	7	43	147	17	121	3.25
Mar 2021	933	18	624	8	45	254	26	189	4.86
Mar 2022	1143	9	740	21	45	371	25	278	6.96
Mar 2023	1132	5	768	23	45	337	25	252	6.31
Mar 2024	1222	7	857	18	58	318	26	235	5.88
Mar 2025	1384	28	963	68	58	403	25	303	7.57
Mar 2026	1702	84	1229	50	86	353	26	261	6.52
TTM	1812	99	1323	68	96	362	—	268	6.63

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	32.49%
FIIs	14.75%
DIIs	34.42%
Public	18.32%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Sep 2023	38.85%	14.24%	34.8%	12.1%
Dec 2023	38.82%	15.27%	34.24%	11.67%
Mar 2024	38.82%	16.73%	33.13%	11.32%
Jun 2024	38.82%	17.84%	32.12%	11.22%
Sep 2024	38.82%	15.85%	32.29%	13.03%
Dec 2024	38.82%	15.68%	32.05%	13.45%
Mar 2025	38.82%	15.44%	31.95%	13.78%
Jun 2025	34.11%	15.54%	31.65%	18.68%
Sep 2025	34.11%	15.03%	32.12%	18.74%
Dec 2025	34.11%	14.33%	32.72%	18.85%
Mar 2026	34.11%	14.57%	32.5%	18.82%
Jun 2026	32.49%	14.75%	34.42%	18.32%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2016	70	191	251	134	646	498	2	18	128	646
Mar 2017	72	252	277	153	753	501	64	22	167	753
Mar 2018	50	-249	666	323	789	576	0	31	182	789
Mar 2019	74	429	187	166	857	567	0	80	210	857
Mar 2020	74	550	186	147	957	559	2	178	218	957
Mar 2021	78	830	131	175	1214	582	8	213	411	1214
Mar 2022	80	1298	18	173	1569	592	13	542	422	1569
Mar 2023	80	1551	4	177	1812	612	16	826	358	1812
Mar 2024	80	1786	326	204	2397	674	292	1062	368	2397
Mar 2025	80	2088	708	313	3189	773	530	1226	660	3189
Mar 2026	80	2349	1526	330	4285	1534	116	1523	1113	4285

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2016	89	-39	-61	-10
Mar 2017	78	-99	25	5
Mar 2018	94	-52	-42	0
Mar 2019	109	-99	-12	-2
Mar 2020	161	-108	-24	28
Mar 2021	291	-317	25	0
Mar 2022	284	-375	76	-15
Mar 2023	271	-238	-15	18
Mar 2024	262	-569	289	-18
Mar 2025	294	-627	339	6
Mar 2026	292	-956	662	-1

Key ratios

Historical financial ratios

Category	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	46	59	56	52	46	29	28	39	44	49	60
Inventory Days	35	43	39	42	44	30	38	—	—	—	—
Days Payable	192	205	189	161	158	155	118	—	—	—	—
Cash Conversion Cycle	-111	-103	-94	-68	-68	-96	-52	39	44	49	60
Working Capital Days	11	26	-72	2	-4	-29	6	12	3	-23	-35
ROCE %	—	15%	6%	3%	23%	30%	31%	23%	17%	16%	13%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of KRISHNA INST OF MED SCI L (KIMS)?

The reported market capitalisation for KRISHNA INST OF MED SCI L (KIMS) is ₹28,796Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of KIMS?

The current price shown for KRISHNA INST OF MED SCI L (KIMS) on Fincrux is ₹686 with a 52-week high/low of ₹858/576.

What is the P/E ratio of KRISHNA INST OF MED SCI L (KIMS)?

The stock P/E for KRISHNA INST OF MED SCI L (KIMS) is 105 on Fincrux, with ROE at 11.5% and ROCE at 13.0%.

What were KIMS latest quarterly results?

For Jun 2026, KRISHNA INST OF MED SCI L (KIMS) reported sales ₹484 Cr and net profit ₹66 Cr (figures in ₹ crore unless noted).

What are KIMS annual sales and net profit?

For TTM, KRISHNA INST OF MED SCI L (KIMS) shows sales of ₹1,812 Cr and net profit of ₹268 Cr on the Fincrux profit & loss statement.

Who owns KRISHNA INST OF MED SCI L (KIMS)?

Latest shareholding for KRISHNA INST OF MED SCI L (KIMS) on Fincrux: Promoters 32.49% (Jun 2026), FIIs 14.75% (Jun 2026), DIIs 34.42% (Jun 2026), Public 18.32% (Jun 2026), No. of Shareholders 94,730% (Jun 2026).

Where can I find KRISHNA INST OF MED SCI L (KIMS) financials?

KRISHNA INST OF MED SCI L (KIMS) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show KIMS balance sheet and cash flow?

Yes. The KRISHNA INST OF MED SCI L (KIMS) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 19 October 2026 at 5:42